| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059929 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 03/10/2011 | US20110059927 Calcium Formate For Use As A Dietary Supplement |
| 03/10/2011 | US20110059913 Compositions and methods for the treatment of gastrointestinal indications |
| 03/10/2011 | US20110059903 Formulations Comprising Linaclotide |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059193 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats |
| 03/10/2011 | US20110059190 Cistus extract containing enriched secondary plant ingredients |
| 03/10/2011 | US20110059172 Therapeutic compositions |
| 03/10/2011 | US20110059136 Methods and Compositions for Treating Inflammatory Bowel Disease |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059095 High affinity human antibodies to human protease-activated receptor-2 |
| 03/10/2011 | US20110059087 Il-17 and il-23 antagonists and methods of using the same |
| 03/10/2011 | US20110059086 Espfu nucleic acids and proteins and uses thereof |
| 03/10/2011 | US20110059060 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile |
| 03/10/2011 | US20110059028 Method for membrane electrolysis and the use of the products obtained by it |
| 03/10/2011 | CA2806539A1 Oral care methods and compositions utilizing chitosan-derivative compounds |
| 03/10/2011 | CA2773234A1 Method of treating eosinophilic esophagitis |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/10/2011 | CA2772218A1 Methods of treating mitochondrial disorders using metalloporphyrins |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292612A2 Crystalline solvated forms of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292244A2 Salt Solution for Colon Cleansing |
| 03/09/2011 | EP2292243A1 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292211A2 Mucoadhesive pharmaceutical formulations |
| 03/09/2011 | EP2109615B1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 03/09/2011 | EP1824475B1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN101984036A Health vinegar and preparation method thereof |
| 03/09/2011 | CN101984035A Health wine and preparation method thereof |
| 03/09/2011 | CN101984034A Health-care wine |
| 03/09/2011 | CN101983718A Novel medicament for treating liver cancer |
| 03/09/2011 | CN101983716A Medicine for treating gastric ulcer and duodenal ulcer and preparation method thereof |
| 03/09/2011 | CN101983702A Traditional Chinese medicine composition for treating stomach deficiency and preparation method thereof |
| 03/09/2011 | CN101983701A Traditional Chinese medicine compound preparation with protective effects on stomach and intestines |
| 03/09/2011 | CN101983696A Traditional Chinese medicine for treating giddy disease |
| 03/09/2011 | CN101983691A Traditional Chinese medicine for treating diabetic constipation |
| 03/09/2011 | CN101983684A Drug for treating gastrosis and preparation method thereof |
| 03/09/2011 | CN101983673A Traditional Chinese medicine for treating diabetic gastroparesis |
| 03/09/2011 | CN101983670A Medicament for treating gallstone |
| 03/09/2011 | CN101983645A Medicament for treating acute appendicitis |
| 03/09/2011 | CN101983643A Traditional Chinese medicine composition for treating cirrhosis and preparation method thereof |
| 03/09/2011 | CN101983639A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/09/2011 | CN101983624A Zusanli massage health promotion stripe |
| 03/09/2011 | CN101703749B Chinese medicament for treating chronic colonitis |
| 03/09/2011 | CN101596262B Medicine for treating habit constipation and preparation method thereof |
| 03/09/2011 | CN101306082B Houkangsan quality control method |
| 03/09/2011 | CN101073350B White Chinese herbaceous peony tea with bowel-relaxing function |
| 03/09/2011 | CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent |
| 03/09/2011 | CN101060828B Surfactant composition |
| 03/08/2011 | US7902399 Fatty acids analogous |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902358 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea |
| 03/08/2011 | US7902221 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 03/08/2011 | US7902220 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 03/08/2011 | US7902179 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
| 03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/08/2011 | CA2557791C Controlled-release pharmaceutical composition and method for producing the same |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2434272C Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 03/08/2011 | CA2432126C Complex of modafinil and cyclodextrin |
| 03/08/2011 | CA2343840C Use of a cytokine-producing lactococcus strain to treat colitis |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011026125A2 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 03/03/2011 | WO2011025344A2 Attenuated salmonella mutants wherein adhesin of bovine pathogenic escherichia coli is transformed, and vaccine composition for preventing and treating bovine colibacillosis and salmonellosis comprising same |
| 03/03/2011 | WO2011025220A2 Liver regeneration accelerator comprising betaine |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024962A1 Therapeutic agent for liver-related diseases |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024932A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024467A1 Orally administrable tablet for intestinal lavage |
| 03/03/2011 | WO2011023689A1 Bifidobacterium longum and functional gi disorders |
| 03/03/2011 | WO2011022838A1 Polyhydroxylated bile acids for treatment of biliary disorders |
| 03/03/2011 | WO2011017502A9 Formulations comprising linaclotide |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | US20110055943 Novel therapeutic targets in inflammatory bowel disease |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054043 Film composition |
| 03/03/2011 | US20110054036 Composition and method for irrigation of a prepared dental root canal |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110053999 4-methylpyrazole formulations for inhibiting ethanol intolerance |